NCT04956315

Brief Summary

We introduced an automatic knee arthrometer (AKA) and aimed to evaluate the repeatability and effectiveness thereof in diagnosing ACL rupture compared with the KT-2000.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
421

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Jun 2020

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

June 30, 2020

Completed
1 day until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 1, 2020

Completed
6 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2020

Completed
6 months until next milestone

First Submitted

Initial submission to the registry

June 27, 2021

Completed
12 days until next milestone

First Posted

Study publicly available on registry

July 9, 2021

Completed
Last Updated

July 9, 2021

Status Verified

July 1, 2021

Enrollment Period

1 day

First QC Date

June 27, 2021

Last Update Submit

July 7, 2021

Conditions

Outcome Measures

Primary Outcomes (1)

  • Side-to-side difference (SSD)

    Side-to-side difference (SSD)at 134 N

    within 3 months after ACL rupture

Study Arms (3)

Examiner effect group

Two examiners performed the test on one healthy subject with both devices for ten consecutive days. We measured the AD of both knees and calculated the ADD of every test. We evaluated the contralateral-side effect by comparing the AD standard deviations of each knee with both devices, and compared the average ADD tested by different examiners with the same device, to estimate examiner effect.

Diagnostic Test: Side-to-side difference (reproducibility)

Method effect group

The experienced examiner performed tests on 20 healthy subjects using both devices. The means and standard deviations of both knees were calculated. We examined the difference in measurements using each device to determine the method effect.

Diagnostic Test: Side-to-side difference (availability)

Equipment effectiveness group

The experienced examiner performed tests on 200 ACL ruptureand 200 healthy subjects using each device. Effectiveness was analyzed using 1.5 mm and 3 mm threshold values in ACL tears.

Diagnostic Test: Side-to-side difference (Accuracy)

Interventions

The experienced examiner performed tests on 20 healthy subjects

Examiner effect group

Two examiners performed the test on one healthy subject with both devices for ten consecutive days.

Method effect group

200 ACL rupture and 200 healthy subjects were recruited as contrast to compare the accuracy of the devices in diagnosing ACL rupture.

Equipment effectiveness group

Eligibility Criteria

Age18 Years - 45 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64)
Sampling MethodNon-Probability Sample
Study Population

one healthy subject was tested with both devices for ten consecutive days to estimate examiner effect; 20 healthy subjects were tested with both devices to determine the method effect; 200 medicine students volunteered as healthy subjects; each with pain-free knees in the last three months, and without a history of knee injury; 200 patients with ACL rupture from our institution were also included.

You may qualify if:

  • patients with ACL rupture from our institution were included. All patients were diagnosed by sports medicine specialists based on clinical manifestation, combined with imaging examinations, and hospitalized for further surgery.

You may not qualify if:

  • Patients aged \<18 or \>45 years, with combined multiple knee ligament injury combinations, and/or limited range of motion of the knee (unable to flex to 20-30°)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Peking university third hospital

Beijing, Beijing Municipality, 100191, China

Location

Study Officials

  • yingfang ao, M.D.

    Peking University Third Hospital

    STUDY CHAIR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

June 27, 2021

First Posted

July 9, 2021

Study Start

June 30, 2020

Primary Completion

July 1, 2020

Study Completion

December 31, 2020

Last Updated

July 9, 2021

Record last verified: 2021-07

Locations